Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Opt ; 55(28): 8007-8015, 2016 Oct 01.
Article in English | MEDLINE | ID: mdl-27828039

ABSTRACT

We present implementation of the energy-efficient and flexible laser beam shaping technique in a high-power and high-energy laser amplifier system. The beam shaping is based on a spatially variable wave plate (SVWP) fabricated by femtosecond laser nanostructuring of glass. We reshaped the initially Gaussian beam into a super-Gaussian (SG) of the 12th order with efficiency of about 50%. The 12th order of the SG beam provided the best compromise between large fill factor, low diffraction on the edges of the active media, and moderate intensity distribution modification during free-space propagation. We obtained 150 mJ pulses of 532 nm radiation. High-energy, pulse duration of 85 ps and the nearly flat-top spatial profile of the beam make it ideal for pumping optical parametric chirped pulse amplification systems.

2.
Am J Otol ; 21(4): 534-42, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10912700

ABSTRACT

OBJECTIVE: It is widely held that an enlarged summating potential (SP) relative to the eighth nerve action potential (AP) is a reflection of endolymphatic hydrops. Aminoglycosides are an accepted treatment for incapacitating Ménière's disease and are known to affect both sensory and secretory cells of the inner ear. The intent of this study was to determine whether this effect on secretory cells could be objectively confirmed by virtue of changes in the electrocochleogram (ECoG) of patients receiving gentamicin therapy for Ménière's disease. STUDY DESIGN: This was a prospective longitudinal study of repeated ECoG measures in three groups of subjects. Ménière's patients undergoing gentamicin treatment were compared with two control groups: individuals with stable Ménière's disease and normal-hearing control subjects. SETTING: The study was conducted at a tertiary referral center. PATIENTS: The sample included 21 normal-hearing subjects, 15 patients with stable unilateral Ménière's disease, and 12 with disabling unilateral Ménière's disease. INTERVENTIONS: For patients with disabling Ménière's disease, gentamicin was administered transtympanically. Audiograms, impedance tests, and ECoG were performed twice for all subjects. MAIN OUTCOME MEASURES: The SP and AP amplitudes, AP latency, and SP/AP ratio of the EcoG were measured. RESULTS: A statistically significant reduction in the SP/AP ratio was observed after gentamicin administration (analysis of variance interaction effect: F2 = 5.64; p = 0.0065). CONCLUSIONS: The significant reduction in the SP/AP ratio in the gentamicin-treated Ménière's group supports the hypothesis that gentamicin improves the electrophysiologic function of the cochlea, possibly by reducing the severity of the associated endolymphatic hydrops.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Audiometry, Evoked Response/methods , Drug Monitoring/methods , Gentamicins/therapeutic use , Meniere Disease/diagnosis , Meniere Disease/drug therapy , Acoustic Impedance Tests , Analysis of Variance , Audiometry , Case-Control Studies , Cochlear Microphonic Potentials , Humans , Meniere Disease/classification , Prospective Studies , Reaction Time , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...